A password will be e-mailed to you.

Mind Medicine made its official public debut on the NEO Exchange, becoming the first psychedelics medicine firm on the up and coming exchange. On Tuesday (March 3), the first psychedelics medicine company to trade publicly on the NEO Exchange made its debut to the market. The team of Mind Medicine (NEO:MMED) opened the market at the NEO offices as part of the public launch for the company. Company co-founder, co-CEO and director JR Rahn told the Investing News Network (INN) this listing represented a big accomplishment for the entire psychedelics space. However, Rahn made the point of classifying his firm strictly as psychedelics medicine, given that he will never move onto the recreational space. That decision comes as a promise to one of the biggest advocates for the company, Kevin O’Leary. Psychedelics Listing Makes Debut on the NEO

thumbnail courtesy of investingnews.com